1. A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humans
- Author
-
Huang, CJ, Butler, AE, Moran, A, Rao, PN, Wagner, JE, Blazar, BR, Rizza, RA, Manivel, JC, and Butler, PC
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Stem Cell Research ,Regenerative Medicine ,Diabetes ,Transplantation ,Metabolic and endocrine ,Adolescent ,Adult ,Aged ,Cell Differentiation ,Child ,Child ,Preschool ,Female ,Fetal Blood ,Humans ,Infant ,Insulin-Secreting Cells ,Male ,Middle Aged ,Stem Cell Transplantation ,Stem Cells ,Transplantation ,Homologous ,Young Adult ,Beta cell ,Cord blood cell ,Stem cell ,Clinical Sciences ,Paediatrics and Reproductive Medicine ,Public Health and Health Services ,Endocrinology & Metabolism ,Clinical sciences ,Public health - Abstract
Aims/hypothesisWe sought to establish if stem cells contained in cord blood cell allografts have the capacity to differentiate into insulin-expressing beta cells in humans.MethodsWe studied pancreases obtained at autopsy from individuals (n = 11) who had prior opposite-sex cord blood transplants to reconstitute haematopoiesis. Pancreatic tissue sections were stained first by XY-fluorescence in situ hybridisation and then insulin immunohistochemistry. Pancreases obtained at autopsy from participants without cord blood cell infusions served as controls (n = 11).ResultsIn the men with prior transplant of female cord blood, there were 3.4 ± 0.3% XX-positive insulin-expressing islet cells compared with 0.32 ± 0.05% (p
- Published
- 2011